MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0085452
Laven Pharma India Private Limited - healthcare in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.27 Cr
▼ 8% YoY
Net profit · FY 2024
₹3.54 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹12.33 Lakh
EBITDA margin 5.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings
About Laven Pharma India Private Limited
Data last updated:
Laven Pharma India Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 27 January 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2005PTC055230. Its GSTIN is 33AABCL1480B1Z5 (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Harakishore Tadiparthy (Whole-Time Director) and Kishan Babu Tadiparthi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/270A Mangadu Main Road Sathyanarayanapuram Chandramouleeswar Nagar Moulivakkam, Chennai, Tamil Nadu, India – 600116.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.27 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹3.54 Lakh (net margin 1.6%) and EBITDA of ₹12.33 Lakh (EBITDA margin 5.4%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 3% over five years.
The company is associated with 1 brand: Laven Pharma. As per MCA filings, the company has open charges of ₹20 Lakh on record.
Laven Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0085452). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website lavenpharmaindia.com.
Company details
CIN U24231TN2005PTC055230
Registration Number 055230
Incorporation Date 27 January 2005
ROC Chennai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0085452
Recognitions & Rankings of Laven Pharma India
Contact details
Laven Pharma India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is lavenpharmaindia.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address1/270A Mangadu Main Road Sathyanarayanapuram Chandramouleeswar Nagar Moulivakkam, Chennai, Tamil Nadu, India – 600116
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Laven Pharma India Private Limited, buy the company report.
Comprehensive company report
Laven Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Laven Pharma India operates one associated brand: Laven Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and marketing of pharmaceutical products in India. | lavenpharmaindia.com |
Business activity
The main business activity of Laven Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Laven Pharma India Private Limited, buy the company report.
Financials of Laven Pharma India Private Limited
FY 2025 filings availableLaven Pharma India Private Limited reported revenue of ₹2.27 Cr (down 8% YoY) for FY 2024.
Revenue · FY 2024
₹2.27 Cr ▼ 8%
Net profit · FY 2024
₹3.54 Lakh margin 1.6%
EBITDA · FY 2024
₹12.33 Lakh margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 6%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▼ 2%
5 years · compounded
▼ 6%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 8% fall in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Laven Pharma India Private Limited, buy the company report.
Board of directors of Laven Pharma India Private Limited
Laven Pharma India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harakishore Tadiparthy | Whole-Time Director | 27 Jan 2005 | 21 Years 9 Months | Current |
| Kishan Babu Tadiparthi | Director | 27 Jan 2005 | 21 Years 9 Months | Current |
Auditor
Laven Pharma India Private Limited is audited by G K REDDY & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G K REDDY & CO | FY 2019 | 016370S |
Shareholding
The shareholding of Laven Pharma India Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Laven Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Feb 2012 | 10343989 | The Karur Vysya Bank Limited | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Laven Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Laven Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Laven Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCL1480B1Z5 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Laven Pharma India Private Limited, buy the company report.
Recent activity
Laven Pharma India Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Koteswari Tadiparthi ceased to be Director on 21 Oct 2023.
AGM
Laven Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Laven Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Koteswari Tadiparthi ceased to be Director.
Ceased
Tadiparthy Venkata Rao ceased to be Director.
Charges
A charge with The Karur Vysya Bank Limited amounted to Rs. 20.00 Lakh with Charge ID 10343989 was registered on 07 Feb 2012.
Appointed
Harakishore Tadiparthy was appointed as Whole-Time Director.
Appointed
Kishan Babu Tadiparthi was appointed as Director.
Incorporation
27 Jan 2005
Laven Pharma India Private Limited was registered on 27 Jan 2005 with Roc Chennai & aged 21 years 9 months as per MCA records.
Frequently asked questions
Laven Pharma India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 27 January 2005 (21+ years old) and is registered under CIN U24231TN2005PTC055230.
Laven Pharma India has 2 current directors:
- Harakishore Tadiparthy - Whole-Time Director
- Kishan Babu Tadiparthi - Director
The latest financial statements of Laven Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Laven Pharma India is 33AABCL1480B1Z5, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Laven Pharma India is U24231TN2005PTC055230. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laven Pharma India was incorporated on 27 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chennai.
Koteswari Tadiparthi ceased to be Director on 21 Oct 2023. Tadiparthy Venkata Rao ceased to be Director on 21 Oct 2023. Harakishore Tadiparthy was appointed as Whole-Time Director on 27 Jan 2005. Laven Pharma India has 4 board changes on record in total.
Yes, Laven Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0085452).
Laven Pharma India can be reached through the website lavenpharmaindia.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Laven Pharma India is at 1270A Mangadu Main Road Sathyanarayanapuram Chandramouleeswar Nagar Moulivakkam, Chennai, Tamil Nadu, India – 600116.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages